NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
Progesterone, Urine FORWARD
Progesterone, Urine FORWARD
Specimen Type Describes the specimen type needed for testing
Specimen Required Defines the optimal specimen. This field describes the type of specimen required to perform the test and the preferred volume to complete testing. The volume allows automated processing, fastest throughput and, when indicated, repeat or reflex testing.
5 mL from a 24-hour urine collection. No preservative. Refrigerate specimen during collection. Send specimen frozen in a plastic, 10-mL urine tube (Supply T068).
Note: 1. Indicate collection volume and duration on order.
2. Patient should not be on any corticosteroid, ACTH, estrogen or gonadotropin medication, if possible,for at least 48 hours prior to start of urine collection.
Specimen Minimum Volume Defines the amount of specimen required to perform an assay once, including instrument and container dead space. Submitting the minimum specimen volume makes it impossible to repeat the test or perform confirmatory or perform reflex testing. In some situations, a minimum specimen volume may result in a QNS (quantity not sufficient) result, requiring a second specimen to be collected.
Specimens other than
Anticoagulants other than
Specimen Stability Information Provides a description of the temperatures required to transport a specimen to the laboratory. Alternate acceptable temperature(s) are also included.
|Urine||Frozen (preferred)||180 days|
Clinical Information Discusses physiology, pathophysiology, and general clinical aspects, as they relate to a laboratory test
Progesterone is a Progestin produced primarily from enzymatic
metabolism of Pregnenolone. It is enzymatically converted to 17-Hydroxy
Progesterone and 11-Deoxycorticosterone. It is secreted by both the
gonads and the adrenal glands. It is bound to Cortisol Binding Globulin
and Albumin, but a small percentage is present in the "Free" bioactive
form. It is excreted into the urine as its conjugated and unconjugated
forms and as Pregnanediol (conjugated and unconjugated). This assay
measures the conjugated and unconjugated forms of Progesterone.
Progesterone is responsible for cellular changes in the cervix, vagina,
and uterus. Levels are lowest in the follicular phase and increase rapidly
following the luteal surge. Progesterone increases greatly during pregnancy.
Measurement of Urine Progesterone can be useful to monitor fertility,
corpus luteum function, endometrial development, and be helpful in
in-vitro fertilization patients yielding an integrated look of Progesterone
activity over a 24-hour period.
Reference Values Describes reference intervals and additional information for interpretation of test results. May include intervals based on age and sex when appropriate. Intervals are Mayo-derived, unless otherwise designated. If an interpretive report is provided, the reference value field will state this.
Adult Males: up to 0.5 ug/24 hours
Adult Females: up to 2.8 ug/24 hours
This test was performed using a kit that has been approved by the
FDA for an alternate matrix. The analytic performance characteristics
of this test for the submitted matrix have been determined by
Inter Science Institute.
Test Performed By: Inter Science Inst
944 West Hyde Park
Inglewood, CA 90302
Supplemental Report Indicates whether the report includes an additional document with charts, images or other enriched information
Day(s) and Time(s) Test Performed Outlines the days and times the test is performed. This field reflects the day and time the sample must be in the testing laboratory to begin the testing process and includes any specimen preparation and processing time required before the test is performed. Some tests are listed as continuously performed, which means assays are performed several times during the day.
Monday through Friday
Analytic Time Defines the amount of time it takes the laboratory to setup and perform the test. This is defined in number of days. The shortest interval of time expressed is "same day/1 day," which means the results may be available the same day that the sample is received in the testing laboratory. One day means results are available 1 day after the sample is received in the laboratory.
Maximum Laboratory Time Defines the maximum time from specimen receipt at Mayo Medical Laboratories until the release of the test result
Performing Laboratory Location The location of the laboratory that performs the test
Inter Science Institute
Test Classification Provides information regarding the medical device classification for laboratory test kits and reagents. Tests may be classified as cleared or approved by the US Food and Drug Administration (FDA) and used per manufacturer's instructions, or as products that do not undergo full FDA review and approval, and are then labeled as an Analyte Specific Reagent (ASR), Investigation Use Only (IUO) product, or a Research Use Only (RUO) product.
This test was performed using a kit that has been approved by the FDA for an alternate matrix. The analytic performance characteristics of this test for the submitted matrix have been determined by Inter Science Institute.
CPT Code Information Provides guidance in determining the appropriate Current Procedural Terminology (CPT) code(s) information for each test or profile. The listed CPT codes reflect Mayo Medical Laboratories interpretation of CPT coding requirements. It is the responsibility of each laboratory to determine correct CPT codes to use for billing.
LOINC® Code Information Provides guidance in determining the Logical Observation Identifiers Names and Codes (LOINC) values for the result codes returned for this test or profile.
|Result ID||Reporting Name||LOINC Code|
|Z0937||Progesterone, U||In Process|